Avalyn Pharma Inc. — Form D

Avalyn Pharma Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-24. The offering totals $62.9M, of which $16.6M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Tiba G AynechiDirectorSan Diego, CA
Jonathan G Leff, M.D.DirectorSan Diego, CA
Bruce G Montgomery, M.D.DirectorSan Diego, CA
Niall G O'DonnellDirectorSan Diego, CA
Ketan G PatelDirectorSan Diego, CA
Naveed G SiddiqiDirectorSan Diego, CA
Bruce G Montgomery, M.D.Executive OfficerSan Diego, CA
Richard G VincentExecutive OfficerSan Diego, CA
Tiba AynechiDirectorSouth San Francisco, CA
Niall O'DonnellDirectorSt. Louis, MO
Daniel D BurgessDirectorSacramento, CA
Ketan PatelDirectorCambridge, MA
Jonathan LeffDirectorNess Ziona, L3
Lyn BaranowskiDirectorSeattle, WA
Lyn BaranowskiExecutive OfficerSeattle, WA
Peter MoldtDirectorSeattle, WA
Cassandra Gianna LucaDirectorSeattle, WA
Jill Gianna CarrollDirectorSeattle, WA
Michael J KamdarDirectorSan Diego, CA
Michael J KamdarExecutive OfficerSan Diego, CA
A. Bruce MontgomeryDirectorSeattle, WA
A. Bruce MontgomeryExecutive OfficerSeattle, WA
Niall Bruce O'DonnellDirectorSeattle, WA
Jonathan Bruce LeffDirectorSeattle, WA
Sofia Bruce IoannidouDirectorSeattle, WA

Other filings by this issuer (6)

FiledFormOfferingSold
2023-10-10D$189.2M$189.2M
2020-05-08D$35.7M$35.5M
2017-05-24D/A$64.9M$18.2M
2015-08-12D/A$2.2M$2.2M
2015-03-24D/A$2.0M$1.7M
2012-11-16D$1.2M$1.1M

More